Advertisement
Mergers and Acquisitions
Subscribe to Mergers and Acquisitions

The Lead

Moberg Pharma Acquires Balmex

April 27, 2015 11:27 am | by Moberg Pharma | News | Comments

Net sales of the brand is trending on an annual rate exceeding $4 million.

Mylan Board Unanimously Rejects Unsolicited Expression of Interest From Teva

April 27, 2015 11:07 am | by PRNewswire | News | Comments

After a comprehensive review, the Mylan board concluded the approach did not meet any of the key...

Teva’s Potential $40 Billion Acquisition of Mylan Could Transform Generics Space

April 24, 2015 11:26 am | by GlobalData | News | Comments

Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’...

Teva Offers to Buy Mylan in $40.1B Cash-And-Stock Deal

April 21, 2015 10:29 am | by The Associated Press | News | Comments

The potential combination would result in a powerhouse of a generic drug developer competing...

View Sample

FREE Email Newsletter

Mylan Comments on Merger Speculation

April 20, 2015 10:36 am | by PRNewswire | News | Comments

Mylan Executive Chairman Robert J. Coury commented, "We note that there has been some media speculation with regard to a potential bid for Mylan by Teva and that this rumor has been circulating for some time."

Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | News | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.

CollabRx and Medytox Solutions Sign Definitive Merger Agreement

April 16, 2015 3:47 pm | by Globe Newswire | News | Comments

Medytox currently owns and operates several healthcare companies, including clinical testing laboratories, an electronic medical records provider, a laboratory information systems company and a medical billing company. CollabRx is a leading informatics company focused on the interpretation of complex molecular and genetic tests in cancer.

Advertisement

Recipharm Equity Investment in Synthonics

April 14, 2015 11:43 am | by Recipharm | News | Comments

$2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016.

Ventana and Astellas Work on Targeted Cancer Treatments

April 14, 2015 11:09 am | by Ventana Medical Systems, Inc. | News | Comments

Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.

Cipher Pharmaceuticals to Acquire INNOCUTIS

April 13, 2015 3:26 pm | by PR Newswire | News | Comments

Cipher Pharmaceuticals Inc. announced it has acquired INNOCUTIS Holdings LLC, a privately held specialty dermatology company, for $45.5 million in cash.

Hi-Tech Pharmaceuticals To Acquire Advanced Pharmaceuticals and Nutritionals

April 13, 2015 3:13 pm | by PRNewswire | News | Comments

The companies said the acquisition creates a top-tiered global OTC pharmaceutical and nutraceutical company.

Roche Acquires CAPP Medical

April 13, 2015 1:33 pm | by Roche | News | Comments

Roche has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans.

Advertisement

Watson-Marlow Acquires ASEPCO Corporation

April 10, 2015 12:29 pm | by Watson-Marlow Fluid Technology Group (WMFTG) | News | Comments

Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of ASEPCO Corporation (Asepco).

Protea Announces Agreement to Acquire vivoPharm

April 9, 2015 2:25 pm | by Globe Newswire | News | Comments

Protea Biosciences Group announced today that it has entered into an agreement dated as of March 31, 2015 for the purchase of vivoPharm Pty Ltd. ("vivoPharm"), a global provider of pharmacology, toxicology and bioanalytical research services, with a portfolio of proprietary oncology models.

Walgreens Aims to Close Nearly 200 U.S. Stores

April 9, 2015 1:49 pm | by TOM MURPHY, AP Business Writer | News | Comments

The closings are the latest example of a strategy shift for a company that was opening about 500 stores a year a decade ago.

Bristol-Myers Squibb Completes Acquisition of Flexus Biosciences

April 9, 2015 12:02 pm | by Bristol-Myers Squibb | News | Comments

Bristol-Myers Squibb has announced that it has completed its acquisition of Flexus Biosciences, Inc.

Mylan Offers About $29B For Rival Generic Drugmaker Perrigo

April 8, 2015 2:28 pm | by MARLEY JAY, AP Business Writer | News | Comments

In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion.

Advertisement

Microbix Signs Virology Distribution Agreement for South Korea

April 6, 2015 12:23 pm | News | Comments

Microbix Biosystems has signed an exclusive distribution agreement with Kim & Friends, Inc. The agreement provides Microbix with improved access to the key South Korean market for its virology products.

TPG Completes Acquisition of Aptalis, Renamed Adare

April 2, 2015 1:07 pm | by Adare Pharmaceuticals | News | Comments

Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed.

Analyst: Biotech M & A 'Arms Race'

April 1, 2015 12:50 pm | by Goldman Small Cap Research | News | Comments

Analyst Rob Goldman says mid-stage biotech companies are being built for potential sale, in an environment of increasing mergers and acquisitions.

Patheon Closes Acquisition of IRIX Pharmaceuticals

April 1, 2015 12:33 pm | by Patheon | News | Comments

Patheon has closed the transaction to acquire IRIX Pharmaceuticals, a company that specializes in making difficult to manufacture Active Pharmaceutical Ingredients (API).

Valeant Pharmaceuticals Completes Acquisition Of Salix Pharmaceuticals

April 1, 2015 12:28 pm | by Valeant Pharmaceuticals International | News | Comments

Valeant Pharmaceuticals International today announced it has completed the previously announced acquisition of Salix Pharmaceuticals.

Panther Biotechnology In Exclusive License Agreement With Northwestern University

April 1, 2015 12:11 pm | by Panther Biotechnology | News | Comments

Panther has licensed from Northwestern University the rights to develop and commercialize new technologies to enhance efficacy and decrease toxic side effects of a novel category of anti-cancer drugs.

Actavis Selling Australian Generic Drug Unit to Amneal

March 31, 2015 11:38 am | by The Associated Press | News | Comments

Actavis PLC is selling its generic drug business in Australia to privately-held Amneal Pharmaceuticals for an undisclosed amount.

Horizon Pharma Buying Hyperion for About $1.1 Billion

March 30, 2015 1:08 pm | by The Associated Press | News | Comments

Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders.

Teva Buying Auspex for $3.2 Billion

March 30, 2015 12:54 pm | by The Associated Press | News | Comments

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.

UnitedHealth Bulks Up For Prescription Drug Cost Battle

March 30, 2015 12:36 pm | by Tom Murphy, AP Business Writer | News | Comments

The nation's largest health insurer, UnitedHealth, will muscle up for its fight against rising prescription drug costs by spending more than $12 billion to buy pharmacy benefits manager Catamaran Corp.

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

March 25, 2015 8:11 am | News | Comments

Sun Pharma today, begins the integration of Ranbaxy's business following the successful closure of its merger.  The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

Pharmaceutical, Biotech Mergers Set Record in 2014

March 19, 2015 1:42 pm | by Andy Szal, Digital Reporter | News | Comments

Mergers and acquisitions in the pharmaceutical and biotechnology sectors set a record in 2014, according to a report by Evaluate Ltd.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading